HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021

HIV検査の世界市場予測(~2021年)

◆タイトル:HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021
◆商品コード:MAM-MD5067
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年3月7日
◆ページ数:139
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、HIV検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、検査種類別分析、製品別分析、需要先別分析、地域別分析、HIV検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The HIV diagnosis market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.5% from 2016 to 2021. The global HIV diagnosis market is segmented based on product, test type, end user, and region. On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables), instruments, and software & services. The consumable segment is expected to register the highest CAGR during the forecast period. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.
On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016. These tests are widely adopted to screening and confirmation of HIV antibodies. Moreover, increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.

On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of HIV diagnosis market in 2016. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.

The major factors contributing to the growth of the global HIV diagnosis market include the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.

The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).

Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the HIV diagnosis market. The report analyses the HIV diagnosis market by product, test type, end user, and region.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the HIV diagnosis market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the HIV diagnosis market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for HIV diagnosis across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the HIV diagnosis market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 SECONDARY DATA 18
2.1.1 KEY DATA FROM SECONDARY SOURCES 18
2.2 PRIMARY DATA 19
2.2.1 KEY DATA FROM PRIMARY SOURCES 20
2.3 MARKET SIZE ESTIMATION 20
2.3.1 BOTTOM-UP APPROACH 21
2.3.2 TOP-DOWN APPROACH 22
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.5 ASSUMPTIONS FOR THE STUDY 24

3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
3.2 CONCLUSION 27

4 PREMIUM INSIGHTS 28
4.1 HIV DIAGNOSTICS: MARKET OVERVIEW 28
4.2 GEOGRAPHIC ANALYSIS: HIV DIAGNOSTICS MARKET, BY TEST TYPE (2016) 29
4.3 GEOGRAPHIC SNAPSHOT OF THE HIV DIAGNOSTICS MARKET 30
4.4 LIFE CYCLE ANALYSIS, BY REGION 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.1.1 DRIVERS 34
5.1.1.1 Growing worldwide prevalence of HIV/AIDS 34
5.1.1.2 Increasing number of blood transfusions and blood donations 35
5.1.1.3 Benefits offered by point-of-care instruments & kits 36
5.1.1.4 Increasing government initiatives 36

5.1.2 RESTRAINTS 37
5.1.2.1 High cost of NAT 37
5.1.2.2 Lack of mandates for NAT in developing countries 37
5.1.3 OPPORTUNITY 38
5.1.3.1 Emerging economies offer lucrative growth opportunities for HIV diagnostics 38
5.1.4 TREND 38
5.1.4.1 Increase in use of home access kits and instruments 38

6 HIV DIAGNOSTICS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 CONSUMABLES 42
6.2.1 ASSAYS AND KITS & REAGENTS 43
6.2.2 OTHER CONSUMABLES 44
6.3 INSTRUMENTS 45
6.4 SOFTWARE & SERVICES 46

7 HIV DIAGNOSTICS MARKET, BY TEST TYPE 47
7.1 INTRODUCTION 48
7.2 ANTIBODY TESTS 50
7.2.1 HIV-1 SCREENING TESTS 51
7.2.1.1 ELISA 52
7.2.1.2 Rapid tests 53
7.2.1.3 Home access dried blood spots 54
7.2.2 HIV-1 ANTIBODY CONFIRMATORY TESTS 54
7.2.2.1 Western blot tests 56
7.2.2.2 Indirect immunofluorescence assays (IFA) 57
7.2.2.3 Line immunoassays 57
7.2.2.4 Radio-immunoprecipitation assays 58
7.2.3 HIV-2 & GROUP O DIAGNOSTIC TESTS 59
7.3 VIRAL LOAD TESTS 60
7.4 CD4 TESTS 61
7.5 TESTS FOR EARLY INFANT DIAGNOSIS 62
7.6 TESTS FOR VIRAL IDENTIFICATION 63

8 HIV DIAGNOSTICS MARKET, BY END USER 64
8.1 INTRODUCTION 65
8.2 DIAGNOSTIC LABORATORIES 66
8.3 HOSPITALS 67
8.4 BLOOD BANKS 68
8.5 HOME CARE SETTINGS 69
8.6 OTHER END USERS 70

9 HIV DIAGNOSTICS MARKET, BY REGION 71
9.1 INTRODUCTION 72
9.2 NORTH AMERICA 74
9.2.1 U.S. 78
9.2.2 CANADA 80
9.3 EUROPE 82
9.4 ASIA 85
9.4.1 CHINA 88
9.4.2 JAPAN 90
9.4.3 INDIA 92
9.4.4 REST OF ASIA (ROA) 94
9.5 REST OF THE WORLD (ROW) 96

10 COMPETITIVE LANDSCAPE 98
10.1 INTRODUCTION 98
10.2 STRATEGIC OVERVIEW 98
10.3 MARKET SHARE ANALYSIS 99
10.4 COMPETITIVE SITUATION AND TRENDS 100
10.4.1 PRODUCT LAUNCHES 101
10.4.2 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS 101
10.4.3 EXPANSIONS 102
10.4.4 OTHER DEVELOPMENTS 103

11 COMPANY PROFILES 104
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 104
11.2 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG) 105
11.3 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.) 107
11.4 ABBOTT LABORATORIES 110
11.5 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION) 112
11.6 THERMO-FISHER SCIENTIFIC INC. 115
11.7 MERCK KGAA 117
11.8 BECTON, DICKINSON & COMPANY 119
11.9 HOLOGIC INC. 121
11.10 ALERE INC. 123
11.11 BIO-RAD LABORATORIES 126

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 129
12.1 INSIGHTS OF INDUSTRY EXPERTS 129
12.2 DISCUSSION GUIDE 130
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 132
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 134
12.5 AVAILABLE CUSTOMIZATIONS 135
12.6 RELATED REPORTS 136
12.7 AUTHOR DETAILS 137

LIST OF TABLES

TABLE 1 GLOBAL HIV PREVALENCE, 2015 34
TABLE 2 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 41
TABLE 3 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014–2021 (USD MILLION) 42
TABLE 4 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION,
2014–2021 (USD MILLION) 43
TABLE 5 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR ASSAYS AND KITS & REAGENTS,
BY REGION, 2014–2021 (USD MILLION) 43
TABLE 6 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER CONSUMABLES,
BY REGION, 2014–2021 (USD MILLION) 44
TABLE 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION,
2014–2021 (USD MILLION) 45
TABLE 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR SOFTWARE & SERVICES,
BY REGION, 2014–2021 (USD MILLION) 46
TABLE 9 HIV DIAGNOSTICS MARKET SIZE, BY TYPE OF TEST, 2014–2021 (USD MILLION) 49
TABLE 10 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY TYPE,
2014–2021 (USD MILLION) 50
TABLE 11 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 12 HIV-1 SCREENING TESTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 52
TABLE 13 HIV-1 SCREENING TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 52
TABLE 14 HIV-1 SCREENING TESTS MARKET SIZE FOR ELISA, BY REGION,
2014–2021 (USD MILLION) 53
TABLE 15 HIV-1 SCREENING TESTS MARKET SIZE FOR RAPID TESTS, BY REGION,
2014–2021 (USD MILLION) 53
TABLE 16 HIV-1 SCREENING TESTS MARKET SIZE FOR HOME ACCESS DRIED BLOOD SPOTS, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 17 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 55
TABLE 18 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 56
TABLE 19 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR WESTERN BLOT TESTS, BY REGION, 2014–2021 (USD MILLION) 56
TABLE 20 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR INDIRECT IFA,
BY REGION, 2014–2021 (USD MILLION) 57
TABLE 21 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR LINE IMMUNOASSAYS, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 22 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR RADIO-IMMUNOPRECIPITATION ASSAYS, BY REGION, 2014–2021 (USD MILLION) 58
TABLE 23 HIV-2 & GROUP O DIAGNOSTIC TESTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 59
TABLE 24 HIV DIAGNOSTICS MARKET SIZE FOR VIRAL LOAD TESTS, BY REGION,
2014–2021 (USD MILLION) 60
TABLE 25 HIV DIAGNOSTICS MARKET SIZE FOR CD4 TESTS, BY REGION,
2014–2021 (USD MILLION) 61
TABLE 26 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR EARLY INFANT DIAGNOSIS,
BY REGION, 2014–2021 (USD MILLION) 62
TABLE 27 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR VIRAL IDENTIFICATION,
BY REGION, 2014–2021 (USD MILLION) 63
TABLE 28 HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 65
TABLE 29 GLOBAL HIV DIAGNOSTIC MARKET SIZE FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2014–2021 (USD MILLION) 66
TABLE 30 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION,
2014–2021 (USD MILLION) 67
TABLE 31 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR BLOOD BANKS, BY REGION,
2014–2021 (USD MILLION) 68
TABLE 32 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOME CARE SETTINGS,
BY REGION, 2014–2021 (USD MILLION) 69
TABLE 33 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER END USERS,
BY REGION, 2014–2021 (USD MILLION 70
TABLE 34 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 35 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 76
TABLE 36 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 77
TABLE 37 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 77
TABLE 38 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 78
TABLE 39 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION) 79
TABLE 40 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 79
TABLE 41 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 80
TABLE 42 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 81
TABLE 43 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 81
TABLE 44 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 81
TABLE 45 NUMBER OF HIV TESTS IN EUROPE, BY COUNTRY, 2014 82
TABLE 46 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 83
TABLE 47 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 83
TABLE 48 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 84
TABLE 49 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 50 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION) 87
TABLE 51 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 88
TABLE 52 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 88
TABLE 53 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 89
TABLE 54 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 89
TABLE 55 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 90
TABLE 56 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2014–2021 (USD MILLION) 91
TABLE 57 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 91
TABLE 58 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 91
TABLE 59 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION) 92
TABLE 60 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 93
TABLE 61 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 93
TABLE 62 ROA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION) 94
TABLE 63 ROA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 95
TABLE 64 ROA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 95
TABLE 65 ROW: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION) 96
TABLE 66 ROW: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 97
TABLE 67 ROW: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 97
TABLE 68 GROWTH STRATEGY MATRIX, 2014–2016 100
TABLE 69 PRODUCT LAUNCHES, 2014–2016 101
TABLE 70 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2014–2016 101
TABLE 71 EXPANSIONS, 2014–2016 102
TABLE 72 OTHER DEVELOPMENTS, 2014–2016 103


LIST OF FIGURES

FIGURE 1 GLOBAL HIV DIAGNOSTICS MARKET SEGMENTATION 15
FIGURE 2 HIV DIAGNOSTICS MARKET: RESEARCH DESIGN 17
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
FIGURE 4 HIV DIAGNOSTICS MARKET: BOTTOM-UP APPROACH 21
FIGURE 5 HIV DIAGNOSTICS MARKET: TOP-DOWN APPROACH 22
FIGURE 6 HIV DIAGNOSTICS MARKET: DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT,
2016 VS. 2021 (USD MILLION) 25
FIGURE 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE,
2016 VS. 2021 (USD MILLION) 26
FIGURE 9 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY END USER,
2016 VS. 2021 (USD MILLION) 26
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE HIV DIAGNOSTICS MARKET 27
FIGURE 11 GLOBAL HIV DIAGNOSTICS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 28
FIGURE 12 ANTIBODY TESTS SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL HIV DIAGNOSTICS MARKET IN 2016 29
FIGURE 13 ASIA PROJECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 31
FIGURE 15 HIV DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 33
FIGURE 16 HIV DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT 40
FIGURE 17 CONSUMABLES WERE THE LARGEST PRODUCT SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016 41
FIGURE 18 ASSAYS AND KITS & REAGENTS WERE THE LARGEST PRODUCT SEGMENT IN 2016 42
FIGURE 19 HIV DIAGNOSTICS MARKET SEGMENTATION, BY TEST TYPE 48
FIGURE 20 ANTIBODY TESTS WERE THE LARGEST TEST SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016 49
FIGURE 21 HIV-1 SCREENING TESTS DOMINATED THE HIV DIAGNOSTICS MARKET FOR ANTIBODY TESTS IN 2016 50
FIGURE 22 ELISA WAS THE LARGEST HIV-1 SCREENING TESTS SEGMENT IN 2016 51
FIGURE 23 WESTERN BLOT TESTS WERE THE LARGEST SEGMENT IN THE HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET IN 2016 55
FIGURE 24 DIAGNOSTIC LABORATORIES COMMANDED THE LARGEST MARKET SHARE IN 2016 65
FIGURE 25 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS IN ASIA OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE HIV DIAGNOSTICS MARKET 72
FIGURE 26 HIV DIAGNOSTICS MARKET IN ASIA TO REGISTER THE HIGHEST CAGR DURING FORECAST PERIOD 73
FIGURE 27 NORTH AMERICA: HIV DIAGNOSTICS MARKET SNAPSHOT 75
FIGURE 28 U.S. TO DOMINATE THE NORTH AMERICAN HIV DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 76
FIGURE 29 ANTIBODY TESTS DOMINATED THE NORTH AMERICAN HIV DIAGNOSTICS MARKET, BY TEST TYPE, IN 2016 77
FIGURE 30 VIRAL LOAD TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE U.S. HIV DIAGNOSTICS MARKET 79
FIGURE 31 ANTIBODY TESTS FORM THE LARGEST SEGMENT IN THE CANADIAN HIV DIAGNOSTICS MARKET IN 2016 80
FIGURE 32 MARKET FOR VIRAL LOAD TESTS IN EUROPE TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 83
FIGURE 33 CHINA DOMINATED THE ASIAN HIV DIAGNOSTICS MARKET IN 2016 85
FIGURE 34 ASIA: HIV DIAGNOSTICS MARKET SNAPSHOT 86
FIGURE 35 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIAN HIV DIAGNOSTICS MARKET IN 2016 87
FIGURE 36 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE HIV DIAGNOSTICS MARKET IN CHINA IN 2016 89
FIGURE 37 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE JAPANESE HIV DIAGNOSTICS MARKET IN 2016 90
FIGURE 38 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE INDIAN HIV DIAGNOSTICS MARKET IN 2016 92
FIGURE 39 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROA HIV DIAGNOSTICS MARKET IN 2016 94
FIGURE 40 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROW HIV DIAGNOSTICS MARKET IN 2016 96
FIGURE 41 PRODUCT LAUNCH WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE HIV DIAGNOSTICS MARKET 98
FIGURE 42 HIV DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 99
FIGURE 43 GEOGRAPHIC REVENUE MIX OF THE TOP SIX MARKET PLAYERS 104
FIGURE 44 SIEMENS AG: COMPANY SNAPSHOT (2016) 105
FIGURE 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2015) 107
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015) 110
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2015) 112
FIGURE 48 THERMO-FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2015) 115
FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT (2015) 117
FIGURE 50 BECTON, DICKINSON & COMPANY.: COMPANY SNAPSHOT (2016) 119
FIGURE 51 HOLOGIC INC.: COMPANY SNAPSHOT (2016) 121
FIGURE 52 ALERE INC: COMPANY SNAPSHOT (2016) 123
FIGURE 53 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2015) 126


【レポートのキーワード】

HIV検査、HIV診断、HIV検査キット、HIV検査試薬、HIV検査サービス、医療、ウエスタンブロット

★調査レポート[HIV検査の世界市場予測(~2021年)] ( HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021 / MAM-MD5067) 販売に関する免責事項
[HIV検査の世界市場予測(~2021年)] ( HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021 / MAM-MD5067) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆